Filing Details
- Accession Number:
- 0001209191-10-007257
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-02-05 12:00:00
- Reporting Period:
- 2010-02-03
- Filing Date:
- 2010-02-05
- Accepted Time:
- 2010-02-05 16:35:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
816284 | Celgene Corp | CELG | Pharmaceutical Preparations (2834) | 222711928 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1247024 | Gilla Kaplan | C/O Celgene Corporation 86 Morris Avenue Summit NJ 07901 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-02-03 | 20,000 | $14.92 | 20,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-02-03 | 20,000 | $58.04 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2010-02-03 | 20,000 | $0.00 | 20,000 | $14.92 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2010-06-20 | No | 4 | M | Direct |
Footnotes
- Option was fully exercisable.
- Option granted pursuant to the Company's 1995 Non-Employee Directors' Incentive Plan.